We take a life sciences first approach to quantum applications and bring together leaders in the life sciences fields to ask the questions that will define best-in-class quantum solutions. We do this through curated gatherings that range from small salons to full scale events.

Audience

Our audience is life sciences executives who are focused on computational science, large data solutions and information technology within their companies in collaboration with researchers and leaders in emerging computational science companies who are committed to finding new solutions to the challenges of drug discovery and development through quantum applications.

Takeway

The significant potential of quantum requires the engagement of thought leaders from diverse fields. We are a unique group of individuals committed to realizing this potential of quantum. Participants in our community have the unique opportunity to shape this potential and be an active contributor to the growth of this industry.

Participating Companies

A Select Example of Participating Companies at our inaugural event, Convergence Quantum 2025: Aitia, Amazon Web Services, Amgen, Armatus, AstraZeneca, Biogen, Center for Ultracold Atoms/Harvard Quantum Initiative, Decoy Therapeutics, Eli Lilly, Energesis Pharmaceuticals, Engine Ventures, IBM, Johnson & Johnson Innovation, Kano Therapeutics, Keysight Technologies, MassVentures, Matrisome Bio, MIT LIGO Lab, MIT Physics Department, Northeastern University, Orionis, Pasqal USA, PathCision Medicine, Psivant Therapeutics, Qognitive, Quantonation, Quantum Technology Center University of Maryland, Qubit Pharmaceuticals, Refolding, Scientia, Tufts QIQC Group, Two Bear Capital, University of Cambridge.